NZ255176A - Substituted diaryl piperazinoacetamide derivatives and pharmaceutical compositions - Google Patents
Substituted diaryl piperazinoacetamide derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ255176A NZ255176A NZ255176A NZ25517693A NZ255176A NZ 255176 A NZ255176 A NZ 255176A NZ 255176 A NZ255176 A NZ 255176A NZ 25517693 A NZ25517693 A NZ 25517693A NZ 255176 A NZ255176 A NZ 255176A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compound
- methyl
- phenyl
- piperazineacetamide
- evaporate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92402435A EP0585500A1 (en) | 1992-09-04 | 1992-09-04 | Diaryl piperazineacetamides as antimuscarinic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ255176A true NZ255176A (en) | 1996-02-27 |
Family
ID=8211704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ255176A NZ255176A (en) | 1992-09-04 | 1993-07-29 | Substituted diaryl piperazinoacetamide derivatives and pharmaceutical compositions |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP0585500A1 (en:Method) |
| JP (1) | JPH08501096A (en:Method) |
| AU (1) | AU668413B2 (en:Method) |
| CA (1) | CA2143744A1 (en:Method) |
| FI (1) | FI951009A0 (en:Method) |
| HU (1) | HUT71890A (en:Method) |
| IL (1) | IL106878A0 (en:Method) |
| MX (1) | MX9305248A (en:Method) |
| NZ (1) | NZ255176A (en:Method) |
| TW (1) | TW281674B (en:Method) |
| WO (1) | WO1994005648A1 (en:Method) |
| ZA (1) | ZA936362B (en:Method) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859295A (en) * | 1994-12-05 | 1999-01-12 | University Of Kentucky Research Foundation | Canavanine analogs and their use as chemotherapeutic agents |
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| TW449590B (en) * | 1995-04-14 | 2001-08-11 | Boehringer Ingelheim Kg | New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| GB9513972D0 (en) * | 1995-07-08 | 1995-09-06 | Merck Sharp & Dohme | Pharmaceutical compositions |
| EP0949242A4 (en) * | 1996-12-24 | 2004-09-08 | Chugai Seiyakukabushiki Kaisha | AROMATIC AMINE DERIVATIVES HAVING AN INHIBITORY ACTION WITH RESPECT TO OUR |
| GB9709972D0 (en) * | 1997-05-19 | 1997-07-09 | Pfizer Ltd | Tetrazoles |
| AU8357198A (en) * | 1997-07-24 | 1999-02-16 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Aminocycloalkane compounds |
| BR9909555A (pt) * | 1998-04-08 | 2000-12-19 | Novartis Ag Novartis S A Novar | Herbicidas |
| US6511980B2 (en) | 2000-05-05 | 2003-01-28 | Ortho Mcneil Pharmaceutical, Inc. | Substituted diamine derivatives useful as motilin antagonists |
| EP1469850B1 (en) | 2002-01-02 | 2013-01-02 | Versi Group, LLC | Method of treating sexual dysfunctions with delta opioid receptor agonist compounds |
| FR2840609A1 (fr) * | 2002-06-05 | 2003-12-12 | Lipha | Derives nitroso de la diphenylamine, compositions les contenant et leur utilisation en tant qu'antioxydants et donneurs spontanes d'oxyde nitrique |
| MXPA05003054A (es) * | 2002-09-20 | 2005-05-27 | Pfizer Prod Inc | Ligandos de amida y sulfonamida para el receptor de estrogenos. |
| US8604055B2 (en) | 2004-12-31 | 2013-12-10 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
| CA2605214C (en) | 2004-12-31 | 2016-07-12 | Reddy Us Therapeutics, Inc. | Benzylamine derivatives as cetp inhibitors |
| TWI498115B (zh) | 2007-12-27 | 2015-09-01 | Daiichi Sankyo Co Ltd | 咪唑羰基化合物 |
| GB0815781D0 (en) * | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| TW201113280A (en) | 2009-07-03 | 2011-04-16 | Nensius Res As | Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the CNS |
| CN103827105B (zh) | 2011-08-18 | 2016-08-17 | 雷迪博士实验室有限公司 | 作为胆固醇酯转移蛋白(cetp)抑制剂的取代的杂环胺化合物 |
| CA2850022C (en) | 2011-09-27 | 2018-05-01 | Dr. Reddy's Laboratories, Ltd. | 5 - benzylaminomethyl - 6 - aminopyrazolo [3,4-b] pyridine derivatives as cholesteryl ester-transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis |
| EP3442947B1 (en) * | 2016-04-15 | 2023-06-07 | Epizyme, Inc. | Amine-substituted aryl or heteroaryl compounds as ehmt1 and ehmt2 inhibitors |
| AU2018254577B2 (en) | 2017-04-21 | 2024-06-13 | Epizyme, Inc. | Combination therapies with EHMT2 inhibitors |
| US20240083872A1 (en) * | 2020-12-28 | 2024-03-14 | Shionogi & Co., Ltd. | Cyclic amine derivatives having serotonin receptor binding activity |
| WO2023018471A1 (en) * | 2021-08-10 | 2023-02-16 | Texas Heart Institute | Piperazine-based agonists of lfa-1 and vla-4 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU209723B (en) * | 1990-10-31 | 1994-10-28 | Richter Gedeon Vegyeszet | Process for producing of piperazine derivatives |
| US5276155A (en) * | 1991-12-20 | 1994-01-04 | G. D. Searle & Co. | Process for the resolution of (±)-α-[2-[acetyl(1-methylethyl)amino]ethyl]-α-(2-chlorophenyl)-1-piperidinebutanamide |
| DE4314962A1 (de) * | 1993-05-06 | 1994-11-10 | Bayer Ag | Substituierte Piperazine |
-
1992
- 1992-09-04 EP EP92402435A patent/EP0585500A1/en not_active Withdrawn
-
1993
- 1993-07-29 CA CA002143744A patent/CA2143744A1/en not_active Abandoned
- 1993-07-29 AU AU47953/93A patent/AU668413B2/en not_active Ceased
- 1993-07-29 NZ NZ255176A patent/NZ255176A/en unknown
- 1993-07-29 FI FI951009A patent/FI951009A0/fi unknown
- 1993-07-29 HU HU9500664A patent/HUT71890A/hu unknown
- 1993-07-29 JP JP6507184A patent/JPH08501096A/ja not_active Withdrawn
- 1993-07-29 WO PCT/US1993/007198 patent/WO1994005648A1/en not_active Application Discontinuation
- 1993-07-29 EP EP93918532A patent/EP0658157A1/en not_active Withdrawn
- 1993-08-30 ZA ZA936362A patent/ZA936362B/xx unknown
- 1993-08-30 MX MX9305248A patent/MX9305248A/es unknown
- 1993-08-31 TW TW082107092A patent/TW281674B/zh active
- 1993-09-02 IL IL106878A patent/IL106878A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9500664D0 (en) | 1995-04-28 |
| WO1994005648A1 (en) | 1994-03-17 |
| FI951009A7 (fi) | 1995-03-03 |
| CA2143744A1 (en) | 1994-03-17 |
| HUT71890A (en) | 1996-02-28 |
| IL106878A0 (en) | 1993-12-28 |
| EP0585500A1 (en) | 1994-03-09 |
| FI951009L (fi) | 1995-03-03 |
| FI951009A0 (fi) | 1995-03-03 |
| AU668413B2 (en) | 1996-05-02 |
| EP0658157A1 (en) | 1995-06-21 |
| TW281674B (en:Method) | 1996-07-21 |
| AU4795393A (en) | 1994-03-29 |
| MX9305248A (es) | 1995-01-31 |
| ZA936362B (en) | 1994-03-28 |
| JPH08501096A (ja) | 1996-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ255176A (en) | Substituted diaryl piperazinoacetamide derivatives and pharmaceutical compositions | |
| JP4250675B2 (ja) | Ｎ−（ピリジン−２−イル）−スルホンアミド誘導体 | |
| JP3449611B2 (ja) | 掻痒症の治療のための新規な４−アリールピペリジン誘導体 | |
| BG63487B1 (bg) | Използване на хетероциклени съединения | |
| CZ350796A3 (en) | Piperazine derivatives as 5ht1a antagonists | |
| KR20120085738A (ko) | 야누스 키나제 억제제로서의 피롤로 ［1,2-ｂ］ 피리다진 유도체 | |
| JP2001502712A (ja) | 束縛されたソマトスタチン・アゴニスト及びアンタゴニスト | |
| JP2006514110A (ja) | Ｉｐ受容体アンタゴニストとしてのフェニルまたはヘテロアリールアミノアルカン誘導体 | |
| EA029097B1 (ru) | Совместные кристаллы и соли ингибиторов ccr3 | |
| CA3047002A1 (en) | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase | |
| JP4757382B2 (ja) | 神経保護作用を有するトリアゾロン | |
| JPH04308560A (ja) | ベンズアミドおよびスルホンアミド低血糖剤 | |
| EP3455212B1 (en) | Inhibitors of protease-activated receptor-2 | |
| JP6178799B2 (ja) | アプレピタントｌ−プロリン溶媒和化合物−組成物及び共結晶 | |
| ZA200202437B (en) | Use of carbonylamino derivatives against CNS disorders. | |
| CN103827111B (zh) | N-杂环取代酰胺衍生物 | |
| AU660969B2 (en) | NMDA antagonists | |
| CN101198605A (zh) | N-(吡啶-2-基)-磺酰胺衍生物 | |
| CZ8197A3 (en) | (1h-indol-4-yl)-piperidine- or tetrahydropyridine ethyl amines and -ethyl carboxamides and pharmaceutical composition containing thereof | |
| JP2003523994A (ja) | 新規ｃｄ２３インヒビター | |
| EP0840609B1 (en) | Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents | |
| WO1995032966A1 (en) | Indole derivatives as prodrugs of 5-ht1-like receptor agonists | |
| HUP0002905A2 (hu) | 2-{4-[4-(4,5-Diklór-2-metilimidazol-1-il)butil]1-1piperazinil}-5-fluorpirimidin, előállítása és gyógyászati alkalmazása | |
| JPS5929672A (ja) | 置換ヘテロサイクリルフエニルスルホニルおよびホスホニルアミジン化合物 | |
| NZ314062A (en) | 4-[1-[2-(pyridin-2-ylaminopropyl)]-piperidin-4-yl]indole derivatives |